Vital Signs Seeking New CFO After Departure Of Ex-Bristol Exec
This article was originally published in The Gray Sheet
Executive Summary
Vital Signs, Inc. plans to consult several executive search firms the week of May 17 to recruit external candidates it will consider along with at least one inside prospect for a vacated CFO slot
You may also be interested in...
Sleep Test Coverage Policy, ResMed/Respironics Talks Could Awaken Market
ResMed plans to work with Respironics to generate data that will raise the public and professional profile of sleep-disordered breathing (SDB) devices, which have an estimated $600 mil. U.S. market potential
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.